PWRN1 low expression facilitates cancer progression and is an unfavorable prognosis factor in breast cancer

PWRN1低表达促进癌症进展,是乳腺癌预后不良的因素。

阅读:2
作者:Hubao Yuan,Yuanwei Liu,Yong Jia,Xiaodong Yang,Dezhen Yang,Ming Dong,Xin Tang

Abstract

Background: Triple-negative breast cancer (TNBC) has a poor prognosis due to metastasis and recurrence. The LncRNA PWRN1 is lowly expressed in breast cancer, so we investigated the regulatory mechanism and prognostic value of PWRN1 in TNBC. Methods: 135 TNBC patients were included. PWRN1 levels and miR-21-5p level were analyzed by RT-qPCR. Independent prognostic factors for TNBC were analyzed using multifactorial Cox regression. CCK-8 was used to test the proliferative capacity of cells. The effects of PWRN1 and miR-21-5p on cell migration and invasive properties were analyzed by Transwell, and their target binding relationship was reported by DLR assay. Results: PWRN1 was lowly expressed in TNBC patients, while miR-21-5p was highly expressed. PWRN1 expressions were downregulated and miR-21-5p levels were upregulated in TNBC tissues. miR-21-5p is a downstream target gene of PWRN1 and their expression is negatively correlated. Overexpression of PWRN1 led to low expression of miR-21-5p, which reduced cell proliferation, migration, and invasion. In addition, PWRN1 was an independent prognostic factor. Patients in the PWRN1 low expression group had shorter overall survival. Conclusions: PWRN1 may be a prognostic marker for TNBC. Overexpression of PWRN1 leads to low expression of miR-21-5p, which affects cell proliferation, migration, and invasive behaviors, thereby preventing poor prognosis in TNBC patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。